NVIDIA Corporation (NASDAQ:NVDA)’s CAO David Shannon sold 2,445 shares of the company’s stock in a transaction dated Tuesday, March 25th. The shares were sold at an average price of $18.50, for a total value of $45,232.50. Following the transaction, the chief accounting officer now directly owns 240,917 shares in the company, valued at approximately $4,456,965. NVIDIA Corporation (NASDAQ:NVDA) shares after opening at $18.34 moved to $18.55 on last trade day and at the end of the day closed at $18.45. Company price to sales ratio in past twelve months was calculated as 2.49 and price to cash ratio as 2.20. NVIDIA Corporation (NASDAQ:NVDA) showed a negative weekly performance of -2.17%.
Arena Pharmaceuticals (NASDAQ:ARNA) SVP William Shanahan, Jr. sold 60,000 shares of the stock on the open market in a transaction that occurred on Tuesday, April 1st. The stock was sold at an average price of $6.37, for a total transaction of $382,200.00. Following the sale, the senior vice president now directly owns 35,000 shares in the company, valued at approximately $222,950. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares advanced 3.25% in last trading session and ended the day on $6.35. ARNA return on equity ratio is recorded as -19.10% and its return on assets is -6.80%. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) yearly performance is -22.56%.
Google Inc. (NASDAQ:GOOG)’s CEO Lawrence Page sold 41,666 shares of GOOG in a transaction dated on April 14, 2014. Google Inc. (NASDAQ:GOOG) shares were sold at an average price of $541.70 for total worth of $22,570,472.20. Google Inc. (NASDAQ:GOOG) shares moved up 0.74% in last trading session and was closed at $536.44, while trading in range of $518.46 – $538.45. Google Inc. (NASDAQ:GOOG) year to date (YTD) performance is -3.94%.
Questcor Pharmaceuticals (NASDAQ:QCOR) CEO Don M. Bailey sold 40,000 shares of the stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $79.65, for a total transaction of $3,186,000.00. Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) weekly performance is -3.02%. On last trading day company shares ended up $78.31. Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) distance from 50-day simple moving average (SMA50) is 14.26%. Analysts mean target price for the company is $87.43.
Leave a Reply